KISS1R: Hallmarks of an Effective Regulator of the Neuroendocrine Axis

Neuroendocrinology

Volumn 101, Issue 3, 2015, Pages 193-210

  Millar, Robert P ^a,b   Babwah, Andy V ^c,d  

^a UNIVERSITY OF PRETORIA   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d CHILDREN S HEALTH RESEARCH INSTITUTE   (Canada)

Author keywords

Desensitization; GnRH neuron; Gonadotrope; G q 11; Internalization; KISS1R; Kisspeptin; Signaling; Arrestin

Indexed keywords

BETA ARRESTIN; COMPLEMENTARY DNA; ESTRADIOL; FOLLITROPIN; G PROTEIN COUPLED RECEPTOR 54; GONADORELIN; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; KISSPEPTIN; KISSPEPTIN 1 RECEPTOR; KISSPEPTIN 10; KISSPEPTIN DERIVATIVE; LUTEINIZING HORMONE; METASTIN; TAK 448; TAK 683; TESTOSTERONE; UNCLASSIFIED DRUG; G PROTEIN COUPLED RECEPTOR; KISS1 PROTEIN, HUMAN; KISS1R PROTEIN, HUMAN; RETINA S ANTIGEN;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CHO CELL LINE; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG INTERMITTENT THERAPY; DRUG TARGETING; FEMALE; FERTILIZATION IN VITRO; GONADORELIN RELEASE; HEK293 CELL LINE; HORMONE RELEASE; HUMAN; HUMAN CELL; HYPOTHALAMIC AMENORRHEA; IN VITRO STUDY; IN VIVO STUDY; INFERTILITY THERAPY; INTERNALIZATION; INTRACELLULAR SIGNALING; MALE; NEUROENDOCRINE SYSTEM; NONHUMAN; OSMOTIC MINIPUMP; PHASE 1 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PROSTATE CANCER; RAT; RECEPTOR DOWN REGULATION; REPRODUCTION; SINGLE DRUG DOSE; ANIMAL; METABOLISM; NERVE CELL; NEUROSECRETION; PROTEIN DEGRADATION; SECRETION (PROCESS); SIGNAL TRANSDUCTION;

ANIMALS; ARRESTINS; FEMALE; GONADOTROPIN-RELEASING HORMONE; GTP-BINDING PROTEIN ALPHA SUBUNITS; HUMANS; KISSPEPTINS; MALE; NEURONS; NEUROSECRETORY SYSTEMS; PROTEOLYSIS; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION;

EID: 84931955545     PISSN: 00283835     EISSN: 14230194     Source Type: Journal    
DOI: 10.1159/000381457     Document Type: Article

References (153)

1. Chan YM, de Guillebon A, Lang-Muritano M, Plummer L, Cerrato F, Tsiaras S, Gaspert A, Lavoie HB, Wu CH, Crowley WF Jr, Amory JK, Pitteloud N, Seminara SB: GnRH1 mutations in patients with idiopathic hypogonadotropic hypogonadism. Proc Natl Acad Sci USA 2009; 106: 11703-11708.
2. Bianco SD, Kaiser UB: The genetic and molecular basis of idiopathic hypogonadotropic hypogonadism. Nat Rev Endocrinol 2009; 5: 569-576.
3. de Roux N, Young J, Misrahi M, Genet R, Chanson P, Schaison G, Milgrom E: A family with hypogonadotropic hypogonadism and mutations in the gonadotropin-releasing hormone receptor. N Engl J Med 1997; 337: 1597-1602.
4. Topaloglu AK, Reimann F, Guclu M, Yalin AS, Kotan LD, Porter KM, Serin A, Mungan NO, Cook JR, Ozbek MN, Imamoglu S, Akalin NS, Yuksel B, O'Rahilly S, Semple RK: TAC3 and TACR3 mutations in familial hypogonadotropic hypogonadism reveal a key role for neurokinin b in the central control of reproduction. Nat Genet 2009; 41: 354-358.
5. Wakabayashi Y, Nakada T, Murata K, Ohkura S, Mogi K, Navarro VM, Clifton DK, Mori Y, Tsukamura H, Maeda K, Steiner RA, Okamura H: Neurokinin B and dynorphin A in kisspeptin neurons of the arcuate nucleus participate in generation of periodic oscillation of neural activity driving pulsatile gonadotropin-releasing hormone secretion in the goat. J Neurosci 2010; 30: 3124-3132.
6. Wakabayashi Y, Yamamura T, Sakamoto K, Mori Y, Okamura H: Electrophysiological and morphological evidence for synchronized GnRH pulse generator activity among kisspeptin/neurokinin B/dynorphin A (KNDY) neurons in goats. J Reprod Dev 2013; 59: 40-48.
7. Grachev P, Millar RP, O'Byrne KT: The role of neurokinin B signalling in reproductive neuroendocrinology. Neuroendocrinology 2014; 99: 7-17.
8. Goodman RL, Coolen LM, Lehman MN: A role for neurokinin B in pulsatile GnRH secretion in the ewe. Neuroendocrinology 2014; 99: 18-32.
9. Hrabovszky E: Neuroanatomy of the human hypothalamic kisspeptin system. Neuroendocrinology 2014; 99: 33-48.
10. Hrabovszky E, Sipos MT, Molnar CS, Ciofi P, Borsay BA, Gergely P, Herczeg L, Bloom SR, Ghatei MA, Dhillo WS, Liposits Z: Low degree of overlap between kisspeptin, neurokinin B, and dynorphin immunoreactivities in the infundibular nucleus of young male human subjects challenges the KNDY neuron concept. Endocrinology 2012; 153: 4978-4989.
11. Rometo AM, Krajewski SJ, Voytko ML, Rance NE: Hypertrophy and increased kisspeptin gene expression in the hypothalamic infundibular nucleus of postmenopausal women and ovariectomized monkeys. J Clin Endocrinol Metab 2007; 92: 2744-2750.
12. Rometo AM, Rance NE: Changes in prodynorphin gene expression and neuronal morphology in the hypothalamus of postmenopausal women. J Neuroendocrinol 2008; 20: 1376-1381.
13. Rance NE, Young WS, 3rd: Hypertrophy and increased gene expression of neurons containing neurokinin-B and substance-P messenger ribonucleic acids in the hypothalami of postmenopausal women. Endocrinology 1991; 128: 2239-2247.
14. de Roux N, Genin E, Carel JC, Matsuda F, Chaussain JL, Milgrom E: Hypogonadotropic hypogonadism due to loss of function of the KISS1-derived peptide receptor GPR54. Proc Natl Acad Sci USA 2003; 100: 10972-10976.
15. Seminara SB, Messager S, Chatzidaki EE, Thresher RR, Acierno JS, Jr, Shagoury JK, Bo-Abbas Y, Kuohung W, Schwinof KM, Hendrick AG, Zahn D, Dixon J, Kaiser UB, Slaugenhaupt SA, Gusella JF, O'Rahilly S, Carlton MB, Crowley WF Jr, Aparicio SA, Colledge WH: The GPR54 gene as a regulator of puberty. N ENgl J Med 2003; 349: 1614-1627.
16. d'Anglemont de Tassigny X, Fagg LA, Dixon JP, Day K, Leitch HG, Hendrick AG, Zahn D, Franceschini I, Caraty A, Carlton MB, Aparicio SA, Colledge WH: Hypogonadotropic hypogonadism in mice lacking a functional Kiss1 gene. Proc Natl Acad Sci USA 2007; 104: 10714-10719.
17. Lapatto R, Pallais JC, Zhang D, Chan YM, Mahan A, Cerrato F, Le WW, Hoffman GE, Seminara SB: Kiss1-/-mice exhibit more variable hypogonadism than Gpr54-/-mice. Endocrinology 2007; 148: 4927-4936.
18. Chan YM, Broder-Fingert S, Paraschos S, Lapatto R, Au M, Hughes V, Bianco SD, Min L, Plummer L, Cerrato F, De Guillebon A, Wu IH, Wahab F, Dwyer A, Kirsch S, Quinton R, Cheetham T, Ozata M, Ten S, Chanoine JP, Pitteloud N, Martin KA, Schiffmann R, Van der Kamp HJ, Nader S, Hall JE, Kaiser UB, Seminara SB: GnRH-deficient phenotypes in humans and mice with heterozygous variants in KISS1/KISS1. J Clin Endocrinol Metab 2011; 96:E1771-E1781.
19. Topaloglu AK, Tello JA, Kotan LD, Ozbek MN, Yilmaz MB, Erdogan S, Gurbuz F, Temiz F, Millar RP, Yuksel B: Inactivating KISS1 mutation and hypogonadotropic hypogonadism. N Engl J Med 2012; 366: 629-635.
20. Kirilov M, Clarkson J, Liu X, Roa J, Campos P, Porteous R, Schutz G, Herbison AE: Dependence of fertility on kisspeptin-GPR54 signaling at the GnRH neuron. Nat Commun 2013; 4: 2492.
21. Novaira HJ, Sonko ML, Hoffman G, Koo Y, Ko C, Wolfe A, Radovick S: Disrupted kisspeptin signaling in GnRH neurons leads to hypogonadotrophic hypogonadism. Mol Endocrinol 2014; 28: 225-238.
22. Ramaswamy S, Seminara SB, Plant TM: Evidence from the agonadal juvenile male rhesus monkey (Macaca mulatta) for the view that the action of neurokinin B to trigger gonadotropin-releasing hormone release is upstream from the kisspeptin receptor. Neuroendocrinology 2011; 94: 237-245.
23. Savoy-Moore RT, Swartz KH: Several GnRH stimulation frequencies differentially release FSH and LH from isolated, perfused rat anterior pituitary cells. Adv Exp Med Biol 1987; 219: 641-645.
24. Wildt L, Hausler A, Marshall G, Hutchison JS, Plant TM, Belchetz PE, Knobil E: Frequency and amplitude of gonadotropin-releasing hormone stimulation and gonadotropin secretion in the rhesus monkey. Endocrinology 1981; 109: 376-385.
25. Thompson IR, Ciccone NA, Xu S, Zaytseva S, Carroll RS, Kaiser UB: GnRH pulse frequency-dependent stimulation of FSHβ transcription is mediated via activation of PKA and CREB. Mol Endocrinol 2013; 27: 606-618.
26. Thompson IR, Kaiser UB: GnRH pulse frequency-dependent differential regulation of LH and FSH gene expression. Mol Cell Endocrinol 2014; 385: 28-35.
27. Lee DK, Nguyen T, O'Neill GP, Cheng R, Liu Y, Howard AD, Coulombe N, Tan CP, Tang-Nguyen AT, George SR, O'Dowd BF: Discovery of a receptor related to the galanin receptors. FEBS Lett 1999; 446: 103-107.
28. Clements MK, McDonald TP, Wang R, Xie G, O'Dowd BF, George SR, Austin CP, Liu Q: Fmrfamide-related neuropeptides are agonists of the orphan G-protein-coupled receptor GPR54. Biochem Biophys Res Commun 2001; 284: 1189-1193.
29. Kotani M, Detheux M, Vandenbogaerde A, Communi D, Vanderwinden JM, Le Poul E, Brezillon S, Tyldesley R, Suarez-Huerta N, Vandeput F, Blanpain C, Schiffmann SN, Vassart G, Parmentier M: The metastasis suppressor gene KISS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54. J Biol Chem 2001; 276: 34631-34636.
30. Muir AI, Chamberlain L, Elshourbagy NA, Michalovich D, Moore DJ, Calamari A, Szekeres PG, Sarau HM, Chambers JK, Murdock P, Steplewski K, Shabon U, Miller JE, Middleton SE, Darker JG, Larminie CG, Wilson S, Bergsma DJ, Emson P, Faull R, Philpott KL, Harrison DC: Axor12, a novel human G protein-coupled receptor, activated by the peptide KISS-1. J Biol Chem 2001; 276: 28969-28975.
31. Ohtaki T, Shintani Y, Honda S, Matsumoto H, Hori A, Kanehashi K, Terao Y, Kumano S, Takatsu Y, Masuda Y, Ishibashi Y, Watanabe T, Asada M, Yamada T, Suenaga M, Kitada C, Usuki S, Kurokawa T, Onda H, Nishimura O, Fujino M: Metastasis suppressor gene kiss-1 encodes peptide ligand of a G-protein-coupled receptor. Nature 2001; 411: 613-617.
32. Wettschureck N, Offermanns S: Mammalian G proteins and their cell type specific functions. Physiol Rev 2005; 85: 1159-1204.
33. Wilkie TM, Scherle PA, Strathmann MP, Slepak VZ, Simon MI: Characterization of Gprotein α subunits in the Gq class: expression in murine tissues and in stromal and hematopoietic cell lines. Proc Natl Acad Sci USA 1991; 88: 10049-10053.
34. Allen Institute for Brain Science: Allen Brain Atlas. http://www.brain-map.org/.
35. Wacker JL, Feller DB, Tang XB, Defino MC, Namkung Y, Lyssand JS, Mhyre AJ, Tan X, Jensen JB, Hague C: Disease-causing mutation in GPR54 reveals the importance of the second intracellular loop for class a G-protein-coupled receptor function. J Biol Chem 2008; 283: 31068-31078.
36. Offermanns S, Simon MI: Gα 15 and Gα 16 couple a wide variety of receptors to phospholipase C. J Biol Chem 1995; 270: 15175-15180.
37. Offermanns S, Negulescu P, Hu YH, Simon MI: Conditionally expressed Gα 15 couples to endogenous receptors in GH3 cells. Naunyn Schmiedebergs Arch Pharmacol 2001; 364: 140-148.
38. Ho MK, Yung LY, Chan JS, Chan JH, Wong CS, Wong YH: Gα(14) links a variety of Gα(i)-and Gα(s)-coupled receptors to the stimulation of phospholipase C. Br J Pharmacol 2001; 132: 1431-1440.
39. Venkatachalam K, Montell C: TRP channels. Annu Rev Biochem 2007; 76: 387-417.
40. Liu X, Lee K, Herbison AE: Kisspeptin excites gonadotropin-releasing hormone neurons through a phospholipase C/calcium-dependent pathway regulating multiple ion channels. Endocrinology 2008; 149: 4605-4614.
41. Pielecka-Fortuna J, Chu Z, Moenter SM: Kisspeptin acts directly and indirectly to increase gonadotropin-releasing hormone neuron activity and its effects are modulated by estradiol. Endocrinology 2008; 149: 1979-1986.
42. Constantin S, Caligioni CS, Stojilkovic S, Wray S: Kisspeptin-10 facilitates a plasma membrane-driven calcium oscillator in gonadotropin-releasing hormone-1 neurons. Endocrinology 2009; 150: 1400-1412.
43. Kroll H, Bolsover S, Hsu J, Kim SH, Bouloux PM: Kisspeptin-evoked calcium signals in isolated primary rat gonadotropin-releasing hormone neurones. Neuroendocrinology 2011; 93: 114-120.
44. Zhang C, Bosch MA, Ronnekleiv OK, Kelly MJ: Kisspeptin activation of TRPC4 channels in female GnRH neurons requires PIP2 depletion and cSrc kinase activation. Endocrinology 2013; 154: 2772-2783.
45. Pampillo M, Camuso N, Taylor JE, Szereszewski JM, Ahow MR, Zajac M, Millar RP, Bhattacharya M, Babwah AV: Regulation of GRP54 signaling by GRK2 and β-arrestin. Mol Endocrinol 2009; 23: 2060-2074.
46. Pawson AJ, Faccenda E, Maudsley S, Lu ZL, Naor Z, Millar RP: Mammalian type I gonadotropin-releasing hormone receptors undergo slow, constitutive, agonist-independent internalization. Endocrinology 2008; 149: 1415-1422.
47. Sallese M, Salvatore L, D'Urbano E, Sala G, Storto M, Launey T, Nicoletti F, Knopfel T, De Blasi A: The G-protein-coupled receptor kinase GRK4 mediates homologous desensitization of metabotropic glutamate receptor 1. FASEB J 2000; 14: 2569-2580.
48. Fourgeaud L, Bessis AS, Rossignol F, Pin JP, Olivo-Marin JC, Hemar A: The metabotropic glutamate receptor mGluR5 is endocytosed by a clathrin-independent pathway. J Biol Chem 2003; 278: 12222-12230.
49. Bhattacharya M, Babwah AV, Godin C, Anborgh PH, Dale LB, Poulter MO, Ferguson SS: Ral and phospholipase D2-dependent pathway for constitutive metabotropic glutamate receptor endocytosis. J Neurosci 2004; 24: 8752-8761.
50. Pula G, Mundell SJ, Roberts PJ, Kelly E: Agonist-independent internalization of metabotropic glutamate receptor 1a is arrestin-and clathrin-dependent and is suppressed by receptor inverse agonists. J Neurosci 2004; 89: 1009-1020.
51. Min L, Soltis K, Reis AC, Xu S, Kuohung W, Jain M, Carroll RS, Kaiser UB: Dynamic kisspeptin receptor trafficking modulates kisspeptin-mediated calcium signaling. Mol Endocrinol 2014; 28: 16-27.
52. Elhabazi K, Humbert JP, Bertin I, Schmitt M, Bihel F, Bourguignon JJ, Bucher B, Becker JA, Sorg T, Meziane H, Petit-Demouliere B, Ilien B, Simonin F: Endogenous mammalian RF-amide peptides, including PrRP, kisspeptin and 26RFa, modulate nociception and morphine analgesia via NPFF receptors. Neuropharmacology 2013; 75: 164-171.
53. Seminara SB, Hayes FJ, Crowley WF Jr: Gonadotropin-releasing hormone deficiency in the human (idiopathic hypogonadotropic hypogonadism and Kallmann's syndrome): pathophysiological and genetic considerations. Endocr Rev 1998; 19: 521-539.
54. Hadziselimovic F, Zivkovic D, Bica DT, Emmons LR: The importance of mini-puberty for fertility in cryptorchidism. J Urol 2005; 174: 1536-1539.
55. Nishio H, Mizuno K, Moritoki Y, Kamisawa H, Kojima Y, Mizuno H, Kohri K, Hayashi Y: Clinical features and testicular morphology in patients with Kallmann syndrome. Urology 2012; 79: 684-686.
56. Boyar RM, Rosenfeld RS, Kapen S, Finkelstein JW, Roffwarg HP, Weitzman ED, Hellman L: Human puberty: simultaneous augmented secretion of luteinizing hormone and testosterone during sleep. J Clin Invest 1974; 54: 609-618.
57. Jakacki RI, Kelch RP, Sauder SE, Lloyd JS, Hopwood NJ, Marshall JC: Pulsatile secretion of luteinizing hormone in children. J Clin Endocrinol Metab 1982; 55: 453-458.
58. Wennink JM, Delemarre-van de Waal HA, van Kessel H, Mulder GH, Foster JP, Schoemaker J: Luteinizing hormone secretion patterns in boys at the onset of puberty measured using a highly sensitive immunoradiometric assay. J Clin Endocrinol Metab 1988; 67: 924-928.
59. Wu FC, Butler GE, Kelnar CJ, Sellar RE: Patterns of pulsatile luteinizing hormone secretion before and during the onset of puberty in boys: A study using an immunoradiometric assay. J Clin Endocrinol Metab 1990; 70: 629-637.
60. Bridges NA, Matthews DR, Hindmarsh PC, Brook CG: Changes in gonadotrophin secretion during childhood and puberty. J Endocrinol 1994; 141: 169-176.
61. Wu FC, Butler GE, Kelnar CJ, Huhtaniemi I, Veldhuis JD: Ontogeny of pulsatile gonadotropin releasing hormone secretion from midchildhood, through puberty, to adulthood in the human male: A study using deconvolution analysis and an ultrasensitive immunofluorometric assay. J Clin Endocrinol Metab 1996; 81: 1798-1805.
62. Iddon CA, Charlton HM, Fink G: Gonadotrophin release in hypogonadal and normal mice after electrical stimulation of the median eminence or injection of luteinizing hormone releasing hormone. J Endocrinol 1980; 85: 105-110.
63. Suter KJ, Pohl CR, Plant TM: The pattern and tempo of the pubertal reaugmentation of open-loop pulsatile gonadotropin-releasing hormone release assessed indirectly in the male rhesus monkey (Macaca mulatta). Endocrinology 1998; 139: 2774-2783.
64. Shahab M, Mastronardi C, Seminara SB, Crowley WF, Ojeda SR, Plant TM: Increased hypothalamic GPR54 signaling: A potential mechanism for initiation of puberty in primates. Proc Natl Acad Sci USA 2005; 102: 2129-2134.
65. Gay VL, Plant TM: Sustained intermittent release of gonadotropin-releasing hormone in the prepubertal male rhesus monkey induced by N-methyl-DL-aspartic acid. Neuroendocrinology 1988; 48: 147-152.
66. Shahab M, Balasubramaniam A, Sahu A, Plant TM: Central nervous system receptors involved in mediating the inhibitory action of neuropeptide Y on luteinizing hormone secretion in the male rhesus monkey (Macaca mulatta). J Neuroendocrinol 2003; 15: 965-970.
67. Ramaswamy S, Pohl CR, McNeilly AS, Winters SJ, Plant TM: The time course of folliclestimulating hormone suppression by recombinant human inhibin A in the adult male rhesus monkey (Macaca mulatta). Endocrinology 1998; 139: 3409-3415.
68. Seminara SB, Dipietro MJ, Ramaswamy S, Crowley WF Jr, Plant TM: Continuous human metastin 45-54 infusion desensitizes G protein-coupled receptor 54-induced gonadotropin-releasing hormone release monitored indirectly in the juvenile male rhesus monkey (Macaca mulatta): A finding with therapeutic implications. Endocrinology 2006; 147: 2122-2126.
69. Crowley WF Jr, Beitins IZ, Vale W, Kliman B, Rivier J, Rivier C, McArthur JW: The biologic activity of a potent analogue of gonadotropinreleasing hormone in normal and hypogonadotropic men. N Engl J Med 1980; 302: 1052-1057.
70. Zimmer CA, Ehrmann DA, Rosenfield RL: Potential diagnostic utility of intermittent administration of short-acting gonadotropin-releasing hormone agonist in gonadotropin deficiency. Fertil Steril 2010; 94: 2697-2702.
71. Sykiotis GP, Hoang XH, Avbelj M, Hayes FJ, Thambundit A, Dwyer A, Au M, Plummer L, Crowley WF Jr, Pitteloud N: Congenital idiopathic hypogonadotropic hypogonadism: evidence of defects in the hypothalamus, pituitary, and testes. J Clin Endocrinol Metab 2010; 95: 3019-3027.
72. Aiyer MS, Chiappa SA, Fink G: A priming effect of luteinizing hormone releasing factor on the anterior pituitary gland in the female rat. J Endocrinol 1974; 62: 573-588.
73. Sollenberger MJ, Carlsen EC, Booth RA Jr, Johnson ML, Veldhuis JD, Evans WS: Nature of gonadotropin-releasing hormone selfpriming of luteinizing hormone secretion during the normal menstrual cycle. Am J Obstet Gynecol 1990; 163: 1529-1534.
74. Crawford JL, McNeilly JR, McNeilly AS: No evidence for pituitary priming to gonadotropin-releasing hormone in relation to luteinizing hormone (LH) secretion prior to the preovulatory LH surge in ewes. Biol Reprod 2004; 71: 224-235.
75. Luttrell LM, Lefkowitz RJ: The role of β-arrestins in the termination and transduction of G-protein-coupled receptor signals. J Cell Sci 2002; 115: 455-465.
76. DeWire SM, Ahn S, Lefkowitz RJ, Shenoy SK: β-Arrestins and cell signaling. Annu Rev Physiol 2007; 69: 483-510.
77. Defea K: β-Arrestins and heterotrimeric Gproteins: collaborators and competitors in signal transduction. Br J Pharmacol 2008; 153(suppl 1):S298-309.
78. Kovacs JJ, Hara MR, Davenport CL, Kim J, Lefkowitz RJ: Arrestin development: emerging roles for β-arrestins in developmental signaling pathways. Dev Cell 2009; 17: 443-458.
79. Shukla AK, Xiao K, Lefkowitz RJ: Emerging paradigms of β-arrestin-dependent seven transmembrane receptor signaling. Trends Biochem Sci 2011; 36: 457-469.
80. Szereszewski JM, Pampillo M, Ahow MR, Offermanns S, Bhattacharya M, Babwah AV: GPR54 regulates ERK1/2 activity and hypothalamic gene expression in a Gα(q/11) and β-arrestin-dependent manner. PLoS One 2010; 5:e12964.
81. Ahow M, Min L, Pampillo M, Nash C, Wen J, Soltis K, Carroll RS, Glidewell-Kenney CA, Mellon PL, Bhattacharya M, Tobet SA, Kaiser UB, Babwah AV: KISS1R signals independently of Gα(q/11) and triggers LH secretion via the β-arrestin pathway in the male mouse. Endocrinology 2014; 155: 4433-4446.
82. Vrecl M, Anderson L, Hanyaloglu A, Mc-Gregor AM, Groarke AD, Milligan G, Taylor PL, Eidne KA: Agonist-induced endocytosis and recycling of the gonadotropin-releasing hormone receptor: effect of β-arrestin on internalization kinetics. Mol Endocrinol 1998; 12: 1818-1829.
83. McArdle CA, Davidson JS, Willars GB: The tail of the gonadotrophin-releasing hormone receptor: desensitization at, and distal to, G protein-coupled receptors. Mol Cell Endocrinol 1999; 151: 129-136.
84. Heding A, Vrecl M, Hanyaloglu AC, Sellar R, Taylor PL, Eidne KA: The rat gonadotropinreleasing hormone receptor internalizes via a β-arrestin-independent, but dynamin-dependent, pathway: addition of a carboxyl-terminal tail confers beta-arrestin dependency. Endocrinology 2000; 141: 299-306.
85. Hislop JN, Everest HM, Flynn A, Harding T, Uney JB, Troskie BE, Millar RP, McArdle CA: Differential internalization of mammalian and non-mammalian gonadotropin-releasing hormone receptors: uncoupling of dynamin-dependent internalization from mitogen-activated protein kinase signaling. J Biol Chem 2001; 276: 39685-39694.
86. Dhami GK, Babwah AV, Sterne-Marr R, Ferguson SS: Phosphorylation-independent regulation of metabotropic glutamate receptor 1 signaling requires G protein-coupled receptor kinase 2 binding to the second intracellular loop. J Biol Chem 2005; 280: 24420-24427.
87. Dhami GK, Dale LB, Anborgh PH, O'Connor-Halligan KE, Sterne-Marr R, Ferguson SS: G protein-coupled receptor kinase 2 regulator of G protein signaling homology domain binds to both metabotropic glutamate receptor 1a and Galphaq to attenuate signaling. J Biol Chem 2004; 279: 16614-16620.
88. Lorenz S, Frenzel R, Paschke R, Breitwieser GE, Miedlich SU: Functional desensitization of the extracellular calcium-sensing receptor is regulated via distinct mechanisms: role of G protein-coupled receptor kinases, protein kinase C and β-arrestins. Endocrinology 2007; 148: 2398-2404.
89. Oakley RH, Laporte SA, Holt JA, Barak LS, Caron MG: Association of beta-arrestin with G protein-coupled receptors during clathrinmediated endocytosis dictates the profile of receptor resensitization. J Biol Chem 1999; 274: 32248-32257.
90. Bianco SD, Vandepas L, Correa-Medina M, Gereben B, Mukherjee A, Kuohung W, Carroll R, Teles MG, Latronico AC, Kaiser UB: KISS1R intracellular trafficking and degradation: effect of the Arg386Pro disease-associated mutation. Endocrinology 2011; 152: 1616-1626.
91. Chretien L, Laporte SA, Escher E, Leduc R, Guillemette G: Use of LiCl in phospholipase C assays masks the impaired functionality of a mutant angiotensin II receptor. Cell Signal 1997; 9: 379-382.
92. Oakley RH, Laporte SA, Holt JA, Caron MG, Barak LS: Differential affinities of visual arrestin, β arrestin1, and β arrestin2 for G protein-coupled receptors delineate two major classes of receptors. J Biol Chem 2000; 275: 17201-17210.
93. Re M, Pampillo M, Savard M, Dubuc C, McArdle CA, Millar RP, Conn PM, Gobeil F Jr, Bhattacharya M, Babwah AV: The human gonadotropin releasing hormone type I receptor is a functional intracellular GPCR expressed on the nuclear membrane. PLoS One 2010; 5:e11489.
94. Kern A, Agoulnik AI, Bryant-Greenwood GD: The low-density lipoprotein class a module of the relaxin receptor (leucine-rich repeat containing G-protein coupled receptor 7): its role in signaling and trafficking to the cell membrane. Endocrinology 2007; 148: 1181-1194.
95. Kern A, Bryant-Greenwood GD: Characterization of relaxin receptor (RXFP1) desensitization and internalization in primary human decidual cells and RXFP1-transfected HEK293 cells. Endocrinology 2009; 150: 2419-2428.
96. Babwah AV, Pampillo M, Min L, Kaiser UB, Bhattacharya M: Single-cell analyses reveal that KISS1R-expressing cells undergo sustained kisspeptin-induced signaling that is dependent upon an influx of extracellular Ca 2+ . Endocrinology 2012; 153: 5875-5887.
97. Mellon PL, Windle JJ, Goldsmith PC, Padula CA, Roberts JL, Weiner RI: Immortalization of hypothalamic GnRH neurons by genetically targeted tumorigenesis. Neuron 1990; 5: 1-10.
98. Feng X, Zhang J, Barak LS, Meyer T, Caron MG, Hannun YA: Visualization of dynamic trafficking of a protein kinase C βII/green fluorescent protein conjugate reveals differences in G protein-coupled receptor activation and desensitization. J Biol Chem 1998; 273: 10755-10762.
99. Thompson EL, Murphy KG, Patterson M, Bewick GA, Stamp GW, Curtis AE, Cooke JH, Jethwa PH, Todd JF, Ghatei MA, Bloom SR: Chronic subcutaneous administration of kisspeptin-54 causes testicular degeneration in adult male rats. Am J Physiol Endocrinol Metab 2006; 291:E1074-E1082.
100. Messager S, Chatzidaki EE, Ma D, Hendrick AG, Zahn D, Dixon J, Thresher RR, Malinge I, Lomet D, Carlton MB, Colledge WH, Caraty A, Aparicio SA: Kisspeptin directly stimulates gonadotropin-releasing hormone release via G protein-coupled receptor 54. Proc Natl Acad Sci USA 2005; 102: 1761-1766.
101. Tovar S, Vazquez MJ, Navarro VM, Fernandez-Fernandez R, Castellano JM, Vigo E, Roa J, Casanueva FF, Aguilar E, Pinilla L, Die guez C, Tena-Sempere M: Effects of single or repeated intravenous administration of kisspeptin upon dynamic LH secretion in conscious male rats. Endocrinology 2006; 147: 2696-2704.
102. Ramaswamy S, Seminara SB, Pohl CR, DiPie tro MJ, Crowley WF Jr, Plant TM: Effect of continuous intravenous administration of human metastin 45-54 on the neuroendocrine activity of the hypothalamic-pituitary-testicular axis in the adult male rhesus monkey (Macaca mulatta). Endocrinology 2007; 148: 3364-3370.
103. Roa J, Vigo E, Garcia-Galiano D, Castellano JM, Navarro VM, Pineda R, Dieguez C, Aguilar E, Pinilla L, Tena-Sempere M: Desensitization of gonadotropin responses to kisspeptin in the female rat: analyses of LH and FSH secretion at different developmental and metabolic states. Am J Physiol Endocrinol Metab 2008; 294:E1088-E1096.
104. Jayasena CN, Nijher GM, Chaudhri OB, Murphy KG, Ranger A, Lim A, Patel D, Mehta A, Todd C, Ramachandran R, Salem V, Stamp GW, Donaldson M, Ghatei MA, Bloom SR, Dhillo WS: Subcutaneous injection of kisspeptin-54 acutely stimulates gonadotropin secretion in women with hypothalamic amenorrhea, but chronic administration causes tachyphylaxis. J Clin Endocrinol Metab 2009; 94: 4315-4323.
105. George JT, Veldhuis JD, Roseweir AK, Newton CL, Faccenda E, Millar RP, Anderson RA: Kisspeptin-10 is a potent stimulator of LH and increases pulse frequency in men. J Clin Endocrinol Metab 2011; 96:E1228-E1236.
106. Young J, George JT, Tello JA, Francou B, Bouligand J, Guiochon-Mantel A, Brailly-Tabard S, Anderson RA, Millar RP: Kisspeptin restores pulsatile LH secretion in patients with neurokinin B signaling deficiencies: physiological, pathophysiological and therapeutic implications. Neuroendocrinology 2013; 97: 193-202.
107. d'Anglemont de Tassigny X, Fagg LA, Carlton MB, Colledge WH: Kisspeptin can stimulate gonadotropin-releasing hormone (GnRH) release by a direct action at GnRH nerve terminals. Endocrinology 2008; 149: 3926-3932.
108. Matsui H, Tanaka A, Yokoyama K, Takatsu Y, Ishikawa K, Asami T, Nishizawa N, Suzuki A, Kumano S, Terada M, Kusaka M, Kitada C, Ohtaki T: Chronic administration of the metastin/kisspeptin analog KISS1-305 or the investigational agent TAK-448 suppresses hypothalamic pituitary gonadal function and depletes plasma testosterone in adult male rats. Endocrinology 2012; 153: 5297-5308.
109. Yamamura T, Wakabayashi Y, Sakamoto K, Matsui H, Kusaka M, Tanaka T, Ohkura S, Okamura H: The effects of chronic subcutaneous administration of an investigational kisspeptin analog, TAK-683, on gonadotropin-releasing hormone pulse generator activity in goats. Neuroendocrinology 2014; 100: 250-264.
110. Scott G, Ahmad I, Howard K, MacLean D, Oliva C, Warrington S, Wilbraham D, Worthington P: Double-blind, randomized, placebo-controlled study of safety, tolerability, pharmacokinetics and pharmacodynamics of TAK-683, an investigational metastin analogue in healthy men. Br J Clin Pharmacol 2013; 75: 381-391.
111. Matsui H, Masaki T, Akinaga Y, Kiba A, Takatsu Y, Nakata D, Tanaka A, Ban J, Matsumoto S, Kumano S, Suzuki A, Ikeda Y, Yamaguchi M, Watanabe T, Ohtaki T, Kusaka M: Pharmacologic profiles of investigational kisspeptin/metastin analogues, TAK-448 and TAK-683, in adult male rats in comparison to the GnRH analogue leuprolide. Eur J Pharmacol 2014; 735: 77-85.
112. MacLean DB, Matsui H, Suri A, Neuwirth R, Colombel M: Sustained exposure to the investigational kisspeptin analog, TAK-448, down-regulates testosterone into the castration range in healthy males and in patients with prostate cancer: results from two phase 1 studies. J Clin Endocrinol Metab 2014; 99:E1445-E1453.
113. Yamamura T, Wakabayashi Y, Sakamoto K, Matsui H, Kusaka M, Tanaka T, Ohkura S, Okamura H: The effects of chronic subcutaneous administration of an investigational kisspeptin analog, TAK-683, on gonadotropin-releasing hormone pulse generator activity in goats. Neuroendocrinology 2014; 100: 250-264.
114. Lowe JD, Bailey CP: Functional selectivity and time-dependence of μ-opioid receptor desensitization at nerve terminals in the mouse ventral tegmental area. Br J Pharmacol 2015; 172: 469-481.
115. Asami T, Nishizawa N, Matsui H, Ishibashi Y, Nishibori K, Horikoshi Y, Nakayama M, Matsumoto S, Tarui N, Yamaguchi M, Matsumoto H, Ohtaki T, Kitada C: Synthesis and biological evaluation of a novel nonapeptide KISS1R agonist with testosteronesuppressive activity (abstract P131-116). Proc 5th Int Pept Symp Program, Kyoto, 2010, p 132.
116. Asami T, Nishozawa N: Metastin derivatives and use thereof. Patent No US7, 960: 348. 2007.
117. Kitada C, Asami T, Nishizawa N: Metastin derivatives and use thereof. Patent No US7, 625: 869. 2006.
118. Matsui H, Takatsu Y, Tanaka A, Asami T, Nishizawa N, Kiba A, Kumano S, Suzuki A, Kusaka M, Ohtaki T: Potent and efficient testosterone suppression by chronic administration of novel metastin analogues, TAK-448 and TAK-683, in male rats. 21st Meet Eur Assoc Cancer Res, Oslo, 2010, p 66.
119. George JT, Veldhuis JD, Tena-Sempere M, Millar RP, Anderson RA: Exploring the pathophysiology of hypogonadism in men with type 2 diabetes: kisspeptin-10 stimulates serum testosterone and LH secretion in men with type 2 diabetes and mild biochemical hypogonadism. Clin Endocrinol 2013; 79: 100-104.
120. Guerriero KA, Keen KL, Millar RP, Terasawa E: Developmental changes in GnRH release in response to kisspeptin agonist and antagonist in female rhesus monkeys (Macaca mulatta): implication for the mechanism of puberty. Endocrinology 2012; 153: 825-836.
121. Chan YM, Butler JP, Sidhoum VF, Pinnell NE, Seminara SB: Kisspeptin administration to women: A window into endogenous kisspeptin secretion and GnRH responsiveness across the menstrual cycle. J Clin Endocrinol Metab 2012; 97:E1458-E1467.
122. George JT, Anderson RA, Millar RP: Kisspeptin-10 stimulation of gonadotrophin secretion in women is modulated by sex steroid feedback. Hum Reprod 2012; 27: 3552-3559.
123. Shaw ND, Histed SN, Srouji SS, Yang J, Lee H, Hall JE: Estrogen negative feedback on gonadotropin secretion: evidence for a direct pituitary effect in women. J Clin Endocrinol Metab 2010; 95: 1955-1961.
124. Kakar SS, Musgrove LC, Devor DC, Sellers JC, Neill JD: Cloning, sequencing, and expression of human gonadotropin releasing hormone (GnRH) receptor. Biochem Biophys Res Commun 1992; 189: 289-295.
125. Janovick JA, Ulloa-Aguirre A, Conn PM: Evolved regulation of gonadotropin-releasing hormone receptor cell surface expression. Endocrine 2003; 22: 317-327.
126. Pawson AJ, Katz A, Sun YM, Lopes J, Illing N, Millar RP, Davidson JS: Contrasting internalization kinetics of human and chicken gonadotropin-releasing hormone receptors mediated by C-terminal tail. J Endocrinol 1998; 156:R9-R12.
127. Millar RP, Lu ZL, Pawson AJ, Flanagan CA, Morgan K, Maudsley SR: Gonadotropin-releasing hormone receptors. Endocr Rev 2004; 25: 235-275.
128. Pawson AJ, McNeilly AS: The pituitary effects of GnRH. Anim Reprod Sci 2005; 88: 75-94.
129. Nankin HR, Troen P: Repetitive luteinizing hormone elevations in serum of normal men. J Clin Endocrinol Metab 1971; 33: 558-560.
130. Nankin HR, Troen P: Overnight patterns of serum luteinizing hormone in normal men. J Clin Endocrinol Metab 1972; 35: 705-710.
131. Boyar R, Perlow M, Hellman L, Kapen S, Weitzman E: Twenty-four hour pattern of luteinizing hormone secretion in normal men with sleep stage recording. J Clin Endocrinol Metab 1972; 35: 73-81.
132. Naftolin F, Yen SS, Tsai CC: Rapid cycling of plasma gonadotrophins in normal men as demonstrated by frequent sampling. Nat New Biol 1972; 236: 92-93.
133. McNeilly AS, Sturdy J, Evans DG, Chard T: Short-term variation in blood levels of prolactin, luteinizing hormone and folliclestimulating hormone in normal men throughout the day. J Endocrinol 1974; 61: 301-302.
134. Santen RJ, Bardin CW: Episodic luteinizing hormone secretion in man: pulse analysis, clinical interpretation, physiologic mechanisms. J Clin Invest 1973; 52: 2617-2628.
135. Baker HW, Santen RJ, Burger HG, De Kretser DM, Hudson B, Pepperell RJ, Bardin CW: Rhythms in the secretion of gonadotropins and gonadal steroids. J Steroid Biochem 1975; 6: 793-801.
136. Winters SJ, Troen P: A reexamination of pulsatile luteinizing hormone secretion in primary testicular failure. J Clin Endocrinol Metab 1983; 57: 432-435.
137. Matsumoto AM, Bremner WJ: Modulation of pulsatile gonadotropin secretion by testosterone in man. J Clin Endocrinol Metab 1984; 58: 609-614.
138. Veldhuis JD, Evans WS, Johnson ML, Wills MR, Rogol AD: Physiological properties of the luteinizing hormone pulse signal: impact of intensive and extended venous sampling paradigms on its characterization in healthy men and women. J Clin Endocrinol Metab 1986; 62: 881-891.
139. Spratt DI, O'Dea LS, Schoenfeld D, Butler J, Rao PN, Crowley WF Jr: Neuroendocrinegonadal axis in men: frequent sampling of LH, FSH, and testosterone. Am J Physiol 1988; 254:E658-E666.
140. Santoro N, Filicori M, Crowley WF Jr: Hypogonadotropic disorders in men and women: diagnosis and therapy with pulsatile gonadotropin-releasing hormone. Endocr Rev 1986; 7: 11-23.
141. Yen SS, Tsai CC, Naftolin F, Vandenberg G, Ajabor L: Pulsatile patterns of gonadotropin release in subjects with and without ovarian function. J Clin Endocrinol Metab 1972; 34: 671-675.
142. Backstrom CT, McNeilly AS, Leask RM, Baird DT: Pulsatile secretion of LH, FSH, prolactin, oestradiol and progesterone during the human menstrual cycle. Clin Endocrinol 1982; 17: 29-42.
143. Reame N, Sauder SE, Kelch RP, Marshall JC: Pulsatile gonadotropin secretion during the human menstrual cycle: evidence for altered frequency of gonadotropin-releasing hormone secretion. J Clin Endocrinol Metab 1984; 59: 328-337.
144. Filicori M, Butler JP, Crowley WF Jr: Neuroendocrine regulation of the corpus luteum in the human: evidence for pulsatile progesterone secretion. J Clin Invest 1984; 73: 1638-1647.
145. Soules MR, Steiner RA, Cohen NL, Bremner WJ, Clifton DK: Nocturnal slowing of pulsatile luteinizing hormone secretion in women during the follicular phase of the menstrual cycle. J Clin Endocrinol Metab 1985; 61: 43-49.
146. Evans WS, Sollenberger MJ, Booth RA Jr, Rogol AD, Urban RJ, Carlsen EC, Johnson ML, Veldhuis JD: Contemporary aspects of discrete peak-detection algorithms. 2. The paradigm of the luteinizing hormone pulse signal in women. Endocr Rev 1992; 13: 81-104.
147. Hall JE, Schoenfeld DA, Martin KA, Crowley WF Jr: Hypothalamic gonadotropin-releasing hormone secretion and follicle-stimulating hormone dynamics during the luteal-follicular transition. J Clin Endocrinol Metab 1992; 74: 600-607.
148. Roseweir AK, Millar RP: Kisspeptin antagonists. Adv Exp Med Biol 2013; 784: 159-186.
149. Millar RP, Roseweir AK, Tello JA, Anderson RA, George JT, Morgan K, Pawson AJ: Kisspeptin antagonists: unraveling the role of kisspeptin in reproductive physiology. Brain Res 2010; 1364: 81-89.
150. Keen KL, Wegner FH, Bloom SR, Ghatei MA, Terasawa E: An increase in kisspeptin-54 release occurs with the pubertal increase in luteinizing hormone-releasing hormone-1 release in the stalk-median eminence of female rhesus monkeys in vivo. Endocrinology 2008; 149: 4151-4157.
151. Liu Z, Ren C, Jones W, Chen P, Seminara SB, Chan YM, Smith NF, Covey JM, Wang J, Chan KK: LC-MS/MS quantification of a neuropeptide fragment kisspeptin-10 (NSC 741805) and characterization of its decomposition product and pharmacokinetics in rats. J Chromatorg B Analyt Technol Biomed Life Sci 2013; 926: 1-8.
152. Roseweir AK, Kauffman AS, Smith JT, Guerriero KA, Morgan K, Pielecka-Fortuna J, Pineda R, Gottsch ML, Tena-Sempere M, Moenter SM, Terasawa E, Clarke IJ, Steiner RA, Millar RP: Discovery of potent kisspeptin antagonists delineate physiological mechanisms of gonadotropin regulation. J Neurosci 2009; 29: 3920-3929.
153. Pineda R, Garcia-Galiano D, Roseweir A, Romero M, Sanchez-Garrido MA, Ruiz-Pino F, Morgan K, Pinilla L, Millar RP, Tena-Sempere M: Critical roles of kisspeptins in female puberty and preovulatory gonadotropin surges as revealed by a novel antagonist. Endocrinology 2010; 151: 722-730.